By Professor Susan Jane Connor

Book Chapters

Connor S; Wu Y, 2024, 'WHAT ARE THE RISKS OF BIOLOGIC THERAPIES AND HOW DO YOU COMMUNICATE THEM TO PATIENTS?', in Curbside Consultation in Ibd 49 Clinical Questions, pp. 115 - 121, http://dx.doi.org/10.1201/9781003523567-23

Journal articles

Mahadevan U; Seow CH; Barnes EL; Chaparro M; Flanagan E; Friedman S; Julsgaard M; Kane S; Ng S; Torres J; Watermeyer G; Yamamoto-Furusho J; Robinson C; Fisher S; Anderson P; Gearry R; Duricova D; Dubinsky M; Long M; Abreu M; Azzam NA; Badre W; Banerjee R; Bell S; Connor S; Dotan I; Ferrante M; Finlayson E; Hokari R; Huang V; Ibanez P; Juliao F; Katsidzira L; Sambuelli A; Selinger C; Wei SC; Williams A; Zaltman C; Lim J; Arima N; Chen W; Hayden N; Lin HC; Ravnborg AB; Mwaura-Ruhio TN; Rous L, 2026, 'Global consensus statement on the management of pregnancy in inflammatory bowel disease', Gut, 75, pp. 208 - 251, http://dx.doi.org/10.1136/gutjnl-2025-336402

Cohen NA; Bettenworth D; Sror N; Khedraki R; Yang Q; Abreu MT; Atreya R; Al-Bawardy B; Connor SJ; D'Haens G; Dotan I; Dignass A; El Ouali S; Feagan B; Feakins R; Gearry R; Gordon IO; Hedin CRH; Hernandez-Rocha C; Kobayashi T; Leibovitzh H; Lu C; Maharshak N; Naseer M; Ollech J; Rubin DT; Sebastian S; Siegmund B; Silverberg MS; Steinwurz F; Torres J; Watermeyer G; Aswani Omprakash T; Frenkel L; Gurizzian P; Silfen A; Tzadok R; Falloon K; Rieder F; Study of Upper Gastrointestinal Manifestations and Management of Crohn's Disease (SUMM-CD) Group , 2026, 'Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study.', Lancet Gastroenterol Hepatol, http://dx.doi.org/10.1016/S2468-1253(25)00347-4

Anand E; Devi J; Ballard DH; Joshi S; Tozer P; Hart A; Antoniou A; Deepak P; Stoker J; Lung P; Ahuja V; Altinmakas E; Anandabaskaran S; Ballard DH; Banerjee R; Behrenbruch C; Bemelman W; Bermejo E; Bhatnagar G; Bislenghi G; Bonifacio C; Buskens C; Caron B; Carvello M; Casanova MJ; Cohen B; Connor S; D'Hoore A; Dane B; Danese S; De Kock I; de Parades V; Deepak P; Dige A; Dillman J; Ding N; Eberhardson M; Fathallah N; Fletcher J; Garcia-Gil JC; Gecse K; Geldof J; Greer ML; Gupta A; Halligan S; Harmath C; Hart A; Holubar S; Horsthuis K; Huang C; Iqbal N; Khaitov S; Kotze P; Laghi A; LeBlanc JF; Lightner A; Lobaton T; Lundby L; Lung P; Maccioni F; McCurdy J; McDonald B; Moran G; Myrelid P; Negård A; Ng S; Paolantonio P; Parian A; Pedersen BG; Plumb A; Powell N; Queiroz N; Rimola J; Carnero PR; Rubin D; Sahnan K; Scharitzer M; Schwartz D; Seale M; Sebastian S; Sharma V; Sood A; Spinelli A; Stoker J; Taylor S; Tielbeek J; Tozer P; Van de Putte D; Verstockt B; Warusavitarne J; Winata LSH; Wong SY; Worley G, 2026, 'Defining Radiological Healing in Perianal Fistulizing Crohn’s Disease: A TOpClass Global Expert Delphi Consensus', Clinical Gastroenterology and Hepatology, 24, pp. 190 - 200, http://dx.doi.org/10.1016/j.cgh.2025.02.009

Caquilpan V; Wu R; Deschenes R; Wilson W; Su WK; Palmer LJ; Petch B; Jackman G; Langford S; Connor SJ; Andrews JM, 2026, 'DOP088 IBD-PERFECT: Development of a performance evaluation and review framework to improve clinical care in Inflammatory Bowel Disease', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.125

Pinnuck B; Su WK; Wilson W; Connor SJ; Andrews JM, 2026, 'Iron deficiency and anaemia in people with inflammatory bowel disease: do we have an ongoing issue of care quality? Crohns Colitis Cure data insights programme', Internal Medicine Journal, 56, pp. 38 - 42, http://dx.doi.org/10.1111/imj.70282

Rivas C; Su WK; Davidson C; Wu R; Wilson W; Andrews JM; Connor SJ, 2026, 'N06 Exploring predictors associated with Inflammatory Bowel Disease (IBD) helpline (HL) utilisation in a regression model: Crohn’s Colitis Cure Data Insights Program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1538

Kaazan P; Caquilpan V; Connor S; Andrews JM, 2026, 'P0452 A high Body Mass Index at baseline is not associated with certain poor IBD-related outcomes', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.633

Kwan T; Wu R; Wilson W; Caquilpan V; Chan P; Rivas C; Connor SJ; Andrews JM, 2026, 'P0454 Automated versus clinician-entered phenotyping of inflammatory bowel disease using an Australasian multicentre real-world database: Crohn’s Colitis Cure Data Insights Program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.635

Wu R; Su WK; Rivas C; Wilson W; Caquilpan V; Kayali D; da Fonseca Pereira C; Connor SJ; Andrews JM, 2026, 'P0507 Ulcerative proctitis: Limited extent but an underestimated burden – insights from the Crohn’s Colitis Cure Data Insights Program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.688

Hartley I; Tassone D; Winata LSH; Sy M; Chow JHC; McCurdy J; Ravikulan A; Gabrielson S; Su H; Xia B; Keung C; Lai KHT; Mak JWY; Welman CJ; Thin L; Chen L; Nguyen A; Srinivasan A; Wu HY; Wei SC; Van Wees J; Sparrow MP; Lai M; Kalasabail S; Borok N; Connor SJ; Chen CY; Shibu R; Mohsen W; An YK; Tan E; Xu Z; Garg M; Lo SW; De Cruz P; Pelly T; Hart A; Ding NJS, 2026, 'P0578 Second-line adalimumab is a viable therapeutic option after infliximab failure in perianal Crohn’s disease: a real-world study', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.759

Chan P; Connor SJ; Knowles SR; Andrews JM, 2026, 'P0583 Building a consumer co-care mobile app – Methodology & consumer insights', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.764

Wu R; Ghali M; Wilson W; Caquilpan V; Rivas C; Lynch K; Haifer C; Walker G; Radford-Smith GL; Lawrance IC; Begun J; Wark G; Verdon C; Andrews JM; Ghaly S; Connor SJ, 2026, 'P0623 Prescribing patterns and persistence of advanced therapies in people with Ulcerative Colitis who are bio-experienced: Insights from the Crohn’s Colitis Care (CCCare) registry', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.804

Ghali M; Wu R; Haifer C; Lynch K; Ng WS; Begun J; Lawrance IC; Radford-Smith GL; Walker G; Shahzad A; Boyapati RK; Rivas C; Caquilpan V; Wilson W; Connor SJ; Andrews JM; Ghaly S, 2026, 'P0633 Prescribing Patterns and Persistence of Advanced Therapies in people with Crohn’s disease with prior advanced therapy: Crohn’s Colitis Cure Data Insights Program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.814

Liu S; Wu R; Petch B; Caquilpan V; Connor SJ; Andrews JM, 2026, 'P0662 Colectomy trends in Ulcerative Colitis amidst an expanding therapeutic landscape: Insights from a clinical care registry', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.843

Chan P; Wu R; Knowles SR; Connor SJ; Andrews JM, 2026, 'P0665 Influenza vaccination uptake in a real-world Australasian Inflammatory Bowel Disease cohort: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.846

Chan P; Wu R; Knowles SR; Andrews JM; Connor SJ, 2026, 'P06705-year Inflammatory Bowel Disease nursing helpline trends in a real-world Australasian cohort: Crohn’s Colitis Cure data insight’s program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.851

Chan P; Wu R; Knowles SR; Andrews JM; Connor SJ, 2026, 'P0736 Skin cancer surveillance uptake in a real-world Australasian Inflammatory Bowel Disease Cohort: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.917

Wu R; Petch B; Deschenes R; Connor SJ; Andrews JM, 2026, 'P0811 The likely return on investment from broad implementation of an Inflammatory Bowel Disease-specific clinical quality registry – towards sustainable Inflammatory Bowel Disease care', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.992

Wu R; Su WK; Wilson W; Caquilpan V; Connor SJ; Andrews JM, 2026, 'P0911 Real-world trends in subcutaneous and intravenous infliximab and vedolizumab use in Inflammatory Bowel Disease from 2021 to 2024: Insights from Crohn’s Colitis Cure Data Insights Program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1092

Chan P; Wu R; Andrews JM; Connor SJ, 2026, 'P1115 Scoping the digital desert in Australian/New Zealand IBD care - A review of consumer available IBD-related mobile apps', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1296

Wu R; Caquilpan V; Deschenes R; Wilson W; Su WK; Palmer LJ; Petch B; Jackman G; Langford S; Andrews JM; Connor SJ, 2026, 'P1216 Measuring what matters in Inflammatory Bowel Disease: Early results from the IBD-PERFECT initiative', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1397

Wu R; Caquilpan V; Wilson W; Andrews JM; Connor SJ, 2026, 'P1239 Divided by distance: Insights into regional disparities in Inflammatory Bowel Disease care across Australia from the Crohn’s Colitis Care Registry', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1420

Petch B; Carter D; Connor SJ; Andrews JM; Gearry RB; Walsh A; Lawrance IC; Whitfield C, 2026, 'P1254 CCCare: A clinician-led, people-centric model for scalable data-driven Improvement in Inflammatory Bowel Disease care', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1435

Wu R; Su WK; Wilson W; Caquilpan V; Andrews JM; Connor SJ; Ghaly S, 2026, 'P1262 Longitudinal trends in benchmarking performance in Inflammatory Bowel Disease care amongst Australasian centres: A real-world registry study from the Crohn’s Colitis Cure Data Insights Program', Journal of Crohn’s and Colitis, 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1443

Giddings HL; Ng K-S; Solomon MJ; Arzivian A; Haifer C; Lin H; Pappas C; Clark D; Deacon A; Radford-Smith G; Ebrahimi N; Wu A; Lewis M; Lim R; Zhang J; Vasudevan A; Demase K; Karp J; Fernandes RG; An Y-K; Ng ZQ; Mackenzie S; Thin L; Greeve T; Moore GT; Connor SJ; Andrews JM; Sparrow MP; Ghaly S, 2025, 'Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era', INFLAMMATORY BOWEL DISEASES, http://dx.doi.org/10.1093/ibd/izaf244

An YK; Lindsay N; Allan N; Khoo E; Fernandes R; Gilmore R; Amiss A; Pham H; Ooi SY; Thin L; Lightowler D; Connor SJ; Williams A; De Cruz P; Li Wai Suen CFD; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow MP; White LS; Bryant R; Ding NS; Leong RW; Van Langenberg DR; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2025, 'Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70322

Mahadevan U; Seow CH; Barnes EL; Chaparro M; Flanagan E; Friedman S; Julsgaard M; Kane S; Ng S; Torres J; Watermeyer G; Yamamoto-Furusho J; Robinson C; Fisher S; Anderson P; Gearry R; Duricova D; Dubinsky M; Long M; Abreu M; Azzam NA; Badre W; Banerjee R; Bell S; Connor S; Dotan I; Ferrante M; Finlayson E; Hokari R; Huang V; Ibanez P; Juliao F; Katsidzira L; Sambuelli A; Selinger C; Wei SC; Williams A; Zaltman C; Lim J; Arima N; Chen W; Hayden N; Lin HC; Ravnborg AB; Mwaura-Ruhio TN; Rous L, 2025, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', Alimentary Pharmacology and Therapeutics, 62, pp. 1125 - 1180, http://dx.doi.org/10.1111/apt.70290

Wu R; Rivas C; Su WK; Deschenes R; Wilson W; Pipicella JL; Connor SJ; Andrews JM; An YK; Begun J; Boyapati R; Dutt S; Gearry RB; Ghaly S; Haifer C; Lawrance IC; Lynch K; Moore G; Radford-Smith G; Shahzad A; Schultz M; Su H; Ng W; Verdon C; Walker G; Wark G, 2025, 'Patterns and Predictors of Steroid Use in a Real-World Inflammatory Bowel Disease Cohort', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70308

Massuger W; Fisher H; Cowan K; Raven L; Goldberg R; Mikocka-Walus A; Giles E; Halmos E; Connor SJ; Pavli P, 2025, 'Top 10 research priorities in inflammatory bowel disease in Australia: findings using the James Lind Alliance approach', Internal Medicine Journal, 55, pp. 2083 - 2086, http://dx.doi.org/10.1111/imj.70201

Mahadevan U; Seow CH; Barnes EL; Chaparro M; Flanagan E; Friedman S; Julsgaard M; Kane S; Ng S; Torres J; Watermeyer G; Yamamoto-Furusho J; Robinson C; Fisher S; Anderson P; Gearry R; Duricova D; Dubinsky M; Long M; Abreu M; Azzam NA; Badre W; Banerjee R; Bell S; Connor S; Dotan I; Ferrante M; Finlayson E; Hokari R; Huang V; Ibanez P; Juliao F; Katsidzira L; Sambuelli A; Selinger C; Wei SC; Williams A; Zaltman C; Lim J; Arima N; Chen W; Hayden N; Lin HC; Brosbol Ravnborg A; Mwaura-Ruhio TN; Rous L, 2025, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', Clinical Gastroenterology and Hepatology, 23, pp. S1 - S60, http://dx.doi.org/10.1016/j.cgh.2025.04.005

Mahadevan U; Seow CH; Barnes EL; Chaparro M; Flanagan E; Friedman S; Julsgaard M; Kane S; Ng S; Torres J; Watermeyer G; Yamamoto-Furusho J; Robinson C; Fisher S; Anderson P; Gearry R; Duricova D; Dubinsky M; Long M; Abreu M; Azzam NA; Badre W; Banerjee R; Bell S; Connor S; Dotan I; Ferrante M; Finlayson E; Hokari R; Huang V; Ibanez P; Juliao F; Katsidzira L; Sambuelli A; Selinger C; Wei SC; Williams A; Zaltman C; Lim J; Arima N; Chen W; Hayden N; Lin HC; Ravnborg AB; Mwaura-Ruhio TN; Rous L, 2025, 'Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease', Inflammatory Bowel Diseases, 31, pp. 2615 - 2664, http://dx.doi.org/10.1093/ibd/izaf171

Little RD; Jayawardana TC; Zhang F; Houshyar Y; Koentgen S; Wu N; Ellepola A; Tavakoli P; Read S; Ho A; Chung A; Boussioutas A; Ward MG; Sparrow MP; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg DA; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold GL; AIM Study consortium , 2025, 'Gut Microbiota Are More Strongly Associated With Impairments in Health-Related Quality of Life Than Disease Activity in Inflammatory Bowel Disease.', Am J Gastroenterol, http://dx.doi.org/10.14309/ajg.0000000000003773

Sun J; Brooks EC; Houshyar Y; Connor SJ; Paven G; Grimm MC; Hold GL, 2025, 'Unravelling the Relationship between Obesity and Inflammatory Bowel Disease', Inflammatory Bowel Diseases, 31, pp. 2547 - 2560, http://dx.doi.org/10.1093/ibd/izaf098

Pipicella JL; Dutt S; Thacker K; Connor SJ; Andrews JM; Vernon-Roberts A, 2025, 'Crohn's Colitis Care, a Disease-Specific Electronic Medical Record, Enhances Data Capture in Pediatric Inflammatory Bowel Disease Care', Jgh Open, 9, http://dx.doi.org/10.1002/jgh3.70153

Whiley PJ; Dixit OVA; Das Gupta M; Patel H; Zhao G; Connor SJ; Summers KM; Hume DA; Pavli P; O'Brien CL, 2025, 'Transcriptomic signatures of host immune responses in aphthous ulcers, the earliest lesions of Crohn's disease, suggest that bacterial uptake, rather than global dysbiosis, is the initiating factor', Immunology and Cell Biology, 103, pp. 473 - 484, http://dx.doi.org/10.1111/imcb.70031

Pipicella JL; Gu B; McNamara J; Wilson W; Palmer LJ; Connor SJ; Andrews JM, 2025, 'Proposal and exploration of a novel score to quantify patient-perceived burden of inflammatory bowel disease under routine care', Internal Medicine Journal, 55, pp. 589 - 598, http://dx.doi.org/10.1111/imj.16634

Abeyratne K; Harb M; Bensted K; Ghaly S; Connor SJ; Andrews JM; Lynch KD, 2025, 'Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas', Internal Medicine Journal, 55, pp. 461 - 466, http://dx.doi.org/10.1111/imj.16648

Little R; Jayawardana T; Zhang F; Houshyar Y; Koentgen S; Wu N; Ellepola A; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'Association of gut microbiota changes and disease activity in patients with Crohn's disease and ulcerative colitis: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2425 - i2426, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1519

Su WK; Mcnamara J; Wilson W; Wark G; Lynch K; Su H; Forbes A; Lawrance I; An YK; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'Consistency and Quality of Inflammatory Bowel Disease care in Australasia; Towards Benchmarking, Crohn's Colitis Cure Data Insight's Program', JOURNAL OF CROHNS & COLITIS, 19, pp. i111 - i112, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0054

Pudipeddi A; Lin H; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', JOURNAL OF CROHNS & COLITIS, 19, pp. I1453 - I1454, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0928

Davidson C; Su WK; Wilson W; Rivas C; Antoniades S; Wark G; Su H; Ghaly S; Grafton R; Andrews JM; Connor SJ, 2025, 'Factors associated with Inflammatory Bowel Disease (IBD) helpline (HL) utilisation: Crohn's Colitis Cure Data Insight's Program', JOURNAL OF CROHNS & COLITIS, 19, pp. i2481 - i2482, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1558

Koentgen S; Cosier D; Tavakoli P; Leach ST; Dutt S; Ghaly S; Connor SJ; Lemberg DA; Lambert K; Hold GL, 2025, 'Fat rich dietary habits: Further increasing IBD risk in first degree relatives', JOURNAL OF CROHNS & COLITIS, 19, pp. i356 - i356, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0192

Su WK; Wilson W; Ng W; Su H; Forbes A; Walker G; Kim A; Giles E; Lawrance I; Dutt S; Brett L; An YK; Lynch K; Connor SJ; Andrews JM, 2025, 'Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn's Colitis Cure Data Insights Program', JOURNAL OF CROHNS & COLITIS, 19, pp. i277 - i278, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0145

Little R; Jayawardana T; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'Gut microbiota changes are associated with type of advanced therapy in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2413 - i2415, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1514

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward MG; Sparrow MP; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G; Australia IBDMAIMS, 2025, 'Impaired health-related quality of life is associated with alterations in gut microbiota signatures in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2422 - i2424, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1518

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Tavakoli P; Sidhu S; Le A; Boussioutas A; Ward MG; Miles S; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G; Australia IBDMAIMS, 2025, 'Microbial signatures associated with Inflammatory Bowel Disease in Australia: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2391 - i2392, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1501

Alsulaibi O; Su WK; Wilson W; Sin L; Ng W; Walker G; Forbes A; Lawrance I; Lynch K; Begun J; Connor SJ; Andrews JM, 2025, 'Mortality and comorbidities in people with Inflammatory Bowel Disease - Crohn's Colitis Cure data insights program', JOURNAL OF CROHNS & COLITIS, 19, pp. i1141 - i1142, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0742

Cabaero AG; Su WK; Wilson W; Rivas C; Antoniades S; Ng W; Forbes A; Arnold K; Grafton R; Andrews JM; Connor SJ, 2025, 'N36 Inflammatory bowel disease helpline use amongst individuals who are culturally and linguistically diverse, Crohn’s Colitis Cure Data Insight’s Programme', Journal of Crohn's and Colitis, 19, pp. i2495 - i2496, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1568

Pudipeddi A; Dhanji P; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'P0257 Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, 19, pp. i689 - i690, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0431

Back to profile page